Suchergebnisse - "Hua, Luoming"

PubPharm (11)

1

Tumor-associated macrophages regulate the function of cytotoxic T lymphocyte through PD-1/PD-L1 pathway in multiple myeloma

enthalten in: Cancer medicine | 2022

von Zhang, J. | Liu, Z. | Cao, P. | +5

2

Tumor‐associated macrophages regulate the function of cytotoxic T lymphocyte through PD‐1/ PD‐L1 pathway in multiple myeloma

enthalten in: Cancer Medicine | 2022

von Zhang, J. | Liu, Z. | Cao, P. | +5

3

Stanozolol improves the progression-free survival of patients with high-risk myelodysplastic syndrome after decitabine treatment

enthalten in: International journal of hematology | 2021

von Liu, Y. | Yang, C. | Xue, H. | +9

4

Stanozolol improves the progression-free survival of patients with high-risk myelodysplastic syndrome after decitabine treatment

enthalten in: International journal of hematology | 2021

von Liu, Y. | Yang, C. | Xue, H. | +9

5

Stanozolol improves the progression-free survival of patients with high-risk myelodysplastic syndrome after decitabine treatment

enthalten in: International journal of hematology | 2021

von Liu, Y. | Yang, C. | Xue, H. | +9

6

Stanozolol improves the progression-free survival of patients with high-risk myelodysplastic syndrome after decitabine treatment

enthalten in: International journal of hematology | 2021

von Liu, Y. | Yang, C. | Xue, H. | +9

7

Ixazomib-based frontline therapy in patients with newly diagnosed multiple myeloma in real-life practice showed comparable efficacy and safety profile with those reported in clinical trial : a multi-center study

enthalten in: Annals of hematology | 2020

von Li, J. | Bao, L. | Xia, Z. | +17

8

Ixazomib-based frontline therapy in patients with newly diagnosed multiple myeloma in real-life practice showed comparable efficacy and safety profile with those reported in clinical trial: a multi-center study

enthalten in: Annals of hematology | 2020

von Li, J. | Bao, L. | Xia, Z. | +17

9

Ixazomib-based frontline therapy in patients with newly diagnosed multiple myeloma in real-life practice showed comparable efficacy and safety profile with those reported in clinical trial: a multi-center study

enthalten in: Annals of hematology | 2020

von Li, J. | Bao, L. | Xia, Z. | +17

10

Ixazomib-based frontline therapy in patients with newly diagnosed multiple myeloma in real-life practice showed comparable efficacy and safety profile with those reported in clinical trial: a multi-center study

enthalten in: Annals of hematology | 2020

von Li, J. | Bao, L. | Xia, Z. | +17